Skip to main content
. Author manuscript; available in PMC: 2021 May 23.
Published in final edited form as: Eur J Clin Nutr. 2017 Apr 12;71(9):1046–1053. doi: 10.1038/ejcn.2017.29

Table 5.

Associations between maternal vitamin B12 status and infant methylmalonic acid

Maternal variables Trimester (T) Model 1a Model 2b
n Beta (s.e.m.) P-value Beta (s.e.m.) P-value
Plasma vitamin B12,c pmol/l T1 76 −0.43 (0.23) 0.060 −0.41 (0.26) 0.113
T2 63 −0.55 (0.20) 0.006 −0.52 (0.20) 0.009
T3 58 −0.55 (0.20) 0.006 −0.49 (0.20) 0.016
Vitamin B12 < 150 pmol/l T1 76 0.47 (0.23) 0.036 0.49 (0.25) 0.046
T2 63 0.65 (0.23) 0.005 0.66 (0.23) 0.004
T3 58 0.80 (0.26) 0.002 0.76 (0.26) 0.004
Plasma MMA,c μmol/ T1 76 0.46 (0.16) 0.003 0.47 (0.16) 0.003
T2 63 0.60 (0.18) 0.001 0.64 (0.17) < 0.001
T3 58 0.36 (0.16) 0.022 0.32 (0.16) 0.049
MMA >0.26 μmol/l T1 76 0.66 (0.23) 0.005 0.63 (0.24) 0.008
T2 63 0.56 (0.24) 0.020 0.66 (0.24) 0.006
T3 58 0.46 (0.25) 0.062 0.42 (0.25) 0.084
Impaired vitamin B12 Statusd T1 76 0.54 (0.23) 0.018 0.51 (0.23) 0.029
T2 63 0.63 (0.23) 0.006 0.68 (0.22) 0.002
T3 58 0.72 (0.25) 0.004 0.68 (0.25) 0.007
Plasma tHcy,c μmol/l T1 76 0.26 (0.15) 0.090 0.24 (0.16) 0.140
T2 63 0.34 (0.18) 0.063 0.34 (0.20) 0.083
T3 58 −0.03 (0.19) 0.869 −0.01 (0.19) 0.951
cB12e T1 76 −0.36 (0.12) 0.003 −0.35 (0.12) 0.005
T2 63 −0.35 (0.12) 0.003 −0.37 (0.13) 0.004
T3 58 −0.29 (0.13) 0.030 −0.33 (0.14) 0.016
Erythrocyte folate,c nmol/l T1 76 −0.87 (0.30) 0.004 −0.94 (0.29) 0.001
T2 63 −0.65 (0.34) 0.058 −0.74 (0.35) 0.036
T3 58 −1.58 (0.42) 0.0002 −1.50 (0.42) < 0.001

Abbreviations: BMI, body mass index; MMA, methylmalonic acid; SLI, standard of living index; tHcy, total homocysteine.

a

Statistical analyses: linear regression models were used to examine associations between maternal vitamin B12 status and infant methylmalonic acid concentrations; models were adjusted for vitamin B12 supplementation and gestational age of sample collection.

b

Statistical analyses: linear regression models were used to examine associations between maternal vitamin B12 status and infant methylmalonic acid concentrations; models were adjusted for vitamin B12 supplementation, gestational age of sample collection, maternal education (⩾ 10th grade vs <10), SLI (⩾ 28 vs <28), baseline total lymphocyte count, baseline BMI.

c

Natural logarithmically transformed to achieve normality.

d

Impaired vitamin B12 status: plasma vitamin B12<150 pmol/l plus MMA>0.26 μmol/l.

e

cB12, a combined indicator of vitamin B12 status modified for three biomarkers (vitamin B12, MMA and tHcy), was calculated using the method developed by Fedosov et al.20